PPM1K and obesity disorder: Pathological increases in circulating BCAA have been recapitulated in genetic animal models of obesity and IR (i.e., ob/ob mice and Zucker fatty rats), which have been attributed to a reduction of BCAA catabolic genes in certain tissues, as well as decreased activity of liver BCKDH [40].